Emerging biological therapy vs. conventional steroid treatment in unilateral sudden sensorineural hearing loss (SSNHL) : a comparative study
Open Access
- 4 August 2026
- journal article
- research article
- Published by Springer Nature in The Egyptian Journal of Otolaryngology
- Vol. 42 (1) , 209
Abstract
Background: Sudden sensorineural hearing loss (SSNHL) is an otologic emergency commonly treated with corticosteroids; however, hearing recovery remains variable. Platelet-rich plasma (PRP), owing to its regenerative and angiogenic properties, has emerged as a potential therapeutic alternative. This study compared the short-term audiological outcomes of intratympanic PRP and intratympanic dexamethasone in patients with unilateral SSNHL. Methods: This retrospective comparative study included 50 patients with unilateral SSNHL treated at a tertiary care centre between 2023 and 2025. Patients were divided into two groups: intratympanic dexamethasone (n=25) and intratympanic PRP (n=25). Injections were administered twice weekly for 2 weeks. Pure tone audiometry (PTA) was assessed at baseline and 1 month. The primary outcome was change in PTA, and hearing improvement was defined as a gain of> 10 dB. Results: This retrospective comparative study included 50 patients with unilateral SSNHL treated at a tertiary care center between 2023 and 2025. Patients received either intratympanic dexamethasone (4 mg/mL; n=25) or intratympanic PRP (n=25), in addition to standard systemic therapy. Four intratympanic injections were administered over two weeks. Pure tone audiometry (PTA) was performed at baseline and one month after treatment initiation. Baseline PTA was comparable between groups (68.4 ± 18.2 dB vs 65.2 ± 17.6 dB; p=0.56). At one month, the PRP group demonstrated significantly better hearing outcomes than the steroid group, with lower mean PTA (34.8 ± 12.9 dB vs 48.6 ± 16.5 dB; p=0.028) and greater mean hearing gain (30.4 ± 11.2 dB vs 19.8 ± 10.4 dB; p=0.028). A higher proportion of PRP-treated patients achieved mild residual hearing loss (60% vs 32%). No serious adverse events were observed in either group. Conclusions: Intratympanic PRP was associated with greater short-term hearing improvement compared with intratympanic dexamethasone in patients with unilateral SSNHL. Although these findings suggest that PRP may represent a promising biologic treatment option, larger prospective randomized controlled trials with longer follow-up are required to confirm its efficacy and establish optimal treatment protocols.Keywords
This publication has 11 references indexed in Scilit:
- Current Role of the Nonsteroid Treatment of Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL): A Narrative ReviewJournal of Clinical Medicine, 2025
- Systematic review and meta-analysis of intratympanic steroid injection in sudden sensory neural hearing loss as initial, combined, or salvage treatment compared to systemic steroids aloneJournal of Otology, 2025
- The Role of Platelet-Rich Plasma in the Management of Sensorineural Hearing Loss: Current Evidence and Emerging TrendsCureus, 2024
- Intratympanic Platelet-Rich Plasma Therapy for Sudden Sensorineural Hearing Loss: A Preliminary Prospective StudyIndian Journal of Otolaryngology and Head & Neck Surgery, 2024
- Idiopathic sudden sensorineural hearing loss: A review focused on the contribution of vascular pathologiesAuris Nasus Larynx, 2024
- Efficacy of Oral versus Intratympanic Steroids in the Treatment of Idiopathic Sudden Sensorineural Hearing Loss: A 1-year Randomized Control TrialIndian Journal of Otology, 2023
- Update on Findings about Sudden Sensorineural Hearing Loss and Insight into Its PathogenesisJournal of Clinical Medicine, 2022
- Intratympanic corticosteroids for sudden sensorineural hearing lossCochrane Database of Systematic Reviews, 2022
- Intratympanic corticosteroid injection as a first-line treatment of the patients with idiopathic sudden sensorineural hearing loss compared to systemic steroid: A systematic review and meta-analysisAmerican Journal of Otolaryngology, 2022
- Clinicoaudiological evaluation of hearing improvement in patients with sensorineural hearing loss using intratympanic platelet rich plasma versus steroid injectionInternational Journal of Otorhinolaryngology and Head and Neck Surgery, 2022